Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
Add more filters

Affiliation country
Publication year range
1.
Eur Spine J ; 29(7): 1499-1504, 2020 07.
Article in English | MEDLINE | ID: mdl-32342283

ABSTRACT

PURPOSE: Cutibacterium acnes (C. acnes) is a gram-positive anaerobic bacillus located in pilosebaceous glands, usually responsible for late postoperative surgical site infections (SSI). A recent study performed in our institution highlighted an unexpected emergence of C. acnes early SSI. One potential explanation was the change of the perioperative antibioprophylaxis (ATB) protocol, which switched from 48 h postoperative cefamandole to intraoperative only cefazoline. The aim of this study was therefore to investigate the influence of the ATB duration on the occurrence of C. acnes early SSI, by comparing the incidence rates during 3 consecutive ATB protocols. METHODS: Between January 2007 and September 2017, all patients who underwent posterior fusion for AIS were retrospectively reviewed. Early C. acnes SSI were reported and compared between 3 periods, during which the ATB protocols were modified. January 2007-February 2012: Intraoperative Cefamandole continued 48 h (protocol 1) March 2012-August 2016: Single shot of intraoperative Cefazoline (protocol 2) September 2016-September 2017: Intraoperative Cefazoline continued 48 h (protocol 3). RESULTS: Fifty-three early SSI (7.2%) were reported among the 732 posterior AIS fusions included. Global incidence of C. acnes infection was 2.9%. The incidence of C. acnes in early SSI increased from 0 to 4.9% between protocol 1 and 2, but was reduced to 1.7% with protocol 3. CONCLUSIONS: Early C acnes SSI can be explained by the difficulty to eradicate this pathogen with current skin preparation procedures and some Beta-lactam antibiotics tolerance. Longer duration antibioprophylaxis is preferable to prevent from early C. acnes SSI.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Cefazolin/administration & dosage , Gram-Positive Bacterial Infections/etiology , Propionibacterium acnes , Scoliosis , Spinal Fusion/adverse effects , Surgical Wound Infection/etiology , Adolescent , Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis/adverse effects , Cefazolin/therapeutic use , Clinical Protocols , Drug Administration Schedule , Female , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/prevention & control , Gram-Positive Bacterial Infections/therapy , Humans , Male , Propionibacterium acnes/isolation & purification , Retrospective Studies , Scoliosis/surgery , Surgical Wound Infection/diagnosis , Surgical Wound Infection/prevention & control , Surgical Wound Infection/therapy , Time Factors
2.
Eur Spine J ; 29(8): 2106, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32562078

ABSTRACT

Unfortunately, the authors first name and family name were incorrectly swapped in the original publication. The complete correct names of the author group is given below.

3.
Acta Paediatr ; 108(5): 933-939, 2019 05.
Article in English | MEDLINE | ID: mdl-30188592

ABSTRACT

AIM: Studies on bone and joint infections (BJI) in infants under three months are rare. We described the clinical and paraclinical features and outcomes of infants hospitalised with BJI under three months of age. METHODS: The French National Hospital Discharge Database provided data on BJIs in infants under three months of age from January 2004 to 2015 in three Parisian Paediatric teaching hospitals. RESULTS: We included 71 infants under three months of age with BJI, the median age was 25 days, and the interquartile range (IQR) was 17-43 days. The most common infection sites were the hip (32%) and knee (32%). Symptoms included pain (94%), limited mobility (87%) and/or fever (52%). There were 11 (15.5%) cases of nosocomial BJI. A pathogen was identified in 51 infants (71.8%), including Streptococcus agalactiae (45%), Staphylococcus aureus (22%) and Escherichia coli (18%). The initial median C-reactive protein test rate was 31 mg/L (IQR 17-68). Of the 34 infants followed for more than one year, four developed severe orthopaedic conditions such as epiphysiodesis, limb length discrepancy, bone necrosis and/or impaired limb function. CONCLUSION: Streptococcus agalactiae was the most common cause of BJI in infants under three months. Orthopaedic sequelae were rare, but severe, and required long-term follow-up.


Subject(s)
Arthritis, Infectious/diagnosis , Arthritis, Infectious/microbiology , Osteomyelitis/diagnosis , Osteomyelitis/microbiology , Age Factors , Arthritis, Infectious/therapy , Escherichia coli Infections , Female , France , Hospitalization , Humans , Infant , Male , Osteomyelitis/therapy , Retrospective Studies , Staphylococcal Infections/diagnosis , Staphylococcal Infections/therapy , Streptococcal Infections/diagnosis , Streptococcal Infections/therapy , Streptococcus agalactiae
4.
Article in English | MEDLINE | ID: mdl-30249695

ABSTRACT

We evaluated the performance of the RESIST-4 O.K.N.V. assay (Coris) with 98 isolates to detect OXA-48-like and KPC-, NDM-, and VIM-type carbapenemases directly on positive human blood cultures. OXA-48-like and KPC-type isolates were correctly detected, but the detection of NDM- and VIM-type carbapenemases was weak and variable. We show that repeating the test on a 4-h subculture improves the detection of NDM- and VIM-type carbapenemases to 100%.


Subject(s)
Bacterial Proteins/genetics , Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Chromatography, Affinity/methods , Enterobacteriaceae Infections/diagnosis , beta-Lactamases/genetics , Blood Culture , Carbapenem-Resistant Enterobacteriaceae/classification , Carbapenem-Resistant Enterobacteriaceae/genetics , Carbapenem-Resistant Enterobacteriaceae/immunology , Chromatography, Affinity/instrumentation , Enterobacteriaceae Infections/microbiology , Gene Expression , Humans , Isoenzymes/genetics , Sensitivity and Specificity
5.
J Clin Microbiol ; 56(9)2018 09.
Article in English | MEDLINE | ID: mdl-29950336

ABSTRACT

The dissemination of carbapenemase-producing Enterobacteriaceae (CPE) is a major threat to public health. Rapid and accurate detection of CPE is essential for initiating appropriate antimicrobial treatment and establishing infection control measures. The carbapenem inactivation method (CIM), which has good sensitivity and specificity but a detection time of 20 h, was recently described. In this study, we evaluated the performances of a new version, the CIMplus test, which allows detection of carbapenemases in 8 h and characterization of carbapenemase classes, according to the Ambler classification, in 20 h. A panel of 110 carbapenem-resistant Enterobacteriaceae strains, including 92 CPE strains (with NDM, VIM, IMP, KPC, GES, OXA-48, and OXA-48-like enzymes), was used to evaluate test performance. Carbapenemase activity was detected at 8 h and 20 h. Characterization of carbapenemase classes, using specific inhibitors, was possible in 20 h. The CIMplus test had sensitivities of 95.7% and 97.8% at 8 h and 20 h, respectively, and a specificity of 94.4%, independent of the culture duration. Using a decision algorithm, this test was successful in identifying the carbapenemase class for 98.9% of tested CPE isolates (87/88 isolates). In total, the characterization was correct for 100%, 96.9%, and 100% of Ambler class A, B, and D isolates, respectively. Therefore, this test allows detection of carbapenemase activity in 8 h and characterization of carbapenemase classes, according to the Ambler classification, in 20 h. The CIMplus test represents a simple, affordable, easy-to-read, and accurate tool that can be used without any specific equipment.


Subject(s)
Anti-Bacterial Agents/metabolism , Bacterial Proteins/analysis , Carbapenems/metabolism , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae/enzymology , Microbial Sensitivity Tests/methods , beta-Lactamases/analysis , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/classification , Bacterial Proteins/metabolism , Carbapenem-Resistant Enterobacteriaceae/drug effects , Carbapenem-Resistant Enterobacteriaceae/enzymology , Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Carbapenems/pharmacology , Enterobacteriaceae/drug effects , Enterobacteriaceae/isolation & purification , Enterobacteriaceae Infections/diagnosis , Humans , Sensitivity and Specificity , Time Factors , beta-Lactamases/classification , beta-Lactamases/metabolism
6.
Eur Spine J ; 27(10): 2543-2549, 2018 10.
Article in English | MEDLINE | ID: mdl-30145656

ABSTRACT

PURPOSE: Surgical site infection (SSI) is a main complication after adolescent idiopathic scoliosis (AIS) surgery. Nasal colonization with S. aureus is a known risk factor for developing nosocomial infections in cardiac surgery. However, the risk in orthopedic surgery remains unclear, especially in spine surgery. This study aims to report the efficacy of a preoperative nasal decontamination program in S. aureus carriers on the incidence of early SSI after AIS posterior surgery. METHODS: Between January 2014 and July 2017, all AIS patients were screened preoperatively with nasal swabs and decontaminated if positive 5 days before surgery. Early SSI was identified, and microorganisms findings were analyzed within nasal carriage and compared to a previous series published before the decontamination program (2007-2011). RESULTS: Among the 331 AIS posterior fusion performed during the study period, incidence of positive nasal swab was 23% (n = 75). Those were preoperatively decontaminated. In comparison with the period before the nasal decontamination program, incidence of S. aureus early SSI significantly decreased from 5.1 to 1.3%, p < 0.05. None of those S. aureus decontaminated patients had an early S. aureus SSI. In all cases of S. aureus infections, S. aureus nasal screening was negative with a mean delay of 315 days (± 115) before surgery, which was significantly different from the global cohort (104 days ± 67, p < 0.05). CONCLUSIONS: Preoperative S. aureus nasal decontamination was associated with a significant decrease in S. aureus SSI. Optimal delay of nasal screening needs to be optimized in order to diagnose intermittent S. aureus carriers. These slides can be retrieved under Electronic Supplementary Material.


Subject(s)
Carrier State , Decontamination , Nasal Cavity/microbiology , Scoliosis/surgery , Staphylococcal Infections , Staphylococcus aureus , Surgical Wound Infection/epidemiology , Adolescent , Carrier State/prevention & control , Carrier State/therapy , Female , Humans , Male , Preoperative Care , Retrospective Studies , Spinal Fusion/adverse effects , Staphylococcal Infections/prevention & control , Staphylococcal Infections/therapy
7.
Antimicrob Agents Chemother ; 60(1): 703-8, 2016 01.
Article in English | MEDLINE | ID: mdl-26574009

ABSTRACT

We describe the genome of a penicillinase-producing Kingella kingae strain (KWG1), the first to be isolated in continental Europe, whose bla(TEM-1) gene was, for the first time in this species, found to be chromosomally inserted. The bla(TEM) gene is located in an integrative and conjugative element (ICE) inserted in Met-tRNA and comprising genes that encode resistance to sulfonamides, streptomycin, and tetracycline. This ICE is homologous to resistance-conferring plasmids of K. kingae and other Gram-negative bacteria.


Subject(s)
Bacterial Proteins/genetics , Chromosomes, Bacterial/chemistry , Gene Expression Regulation, Bacterial , Genome, Bacterial , Kingella kingae/genetics , beta-Lactamases/genetics , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/metabolism , Chromosome Mapping , Drug Resistance, Bacterial/genetics , Gene Ontology , Humans , Kingella kingae/drug effects , Kingella kingae/isolation & purification , Kingella kingae/metabolism , Molecular Sequence Annotation , Neisseriaceae Infections/microbiology , Plasmids/chemistry , Plasmids/metabolism , Streptomycin/pharmacology , Sulfonamides/pharmacology , Tetracycline/pharmacology , beta-Lactamases/metabolism
8.
BMC Infect Dis ; 15: 236, 2015 Jun 21.
Article in English | MEDLINE | ID: mdl-26093673

ABSTRACT

BACKGROUND: After the implementation of pneumococcal conjugate vaccines (PCVs), the marked shift in Streptococcus pneumoniae (Pnc) serotype distribution led to a modification in pneumococcal antibiotic susceptibility. In 2011, the pattern of antibiotic prescription in France for acute otitis media in infants was greatly modified, with decreased use of third-generation cephalosporins and amoxicillin-clavulanate replaced by amoxicillin alone. To assess antibiotic strategies, here we measured the antibiotic susceptibility of Pnc and Haemophilus influenzae (Hi) isolated from nasopharyngeal flora in infants with acute otitis media in the 13-valent PCV (PCV13) era in France. METHODS: From November 2006 to June 2013, 77 pediatricians obtained nasopharyngeal swabs from infants (6 to 24 months old) with acute otitis media. The swabs were sent for analysis to the national reference centre for pneumococci in France. Demographics, medical history, and physical examination findings were recorded. RESULTS: We examined data for 7200 children, 3498 in the pre-PCV13 period (2006-2009) and 3702 in the post-PCV13 period (2010-2013). The Pnc carriage rate decreased from 57.9% to 54.2% between the 2 periods, and the proportion of pneumococcal strains with reduced susceptibility to penicillin or resistant to penicillin decreased from 47.1% to 39% (P < 0.0001). The Hi carriage rate increased from 48.2% to 52.4%, with the proportion of ß-lactamase-producing strains decreasing from 17.1% to 11.9% and the proportion of ß-lactamase-nonproducing, ampicillin-resistant strains remaining stable, from 7.7% to 8.2%. We did not identify any risk factor associated with carriage of ß-lactamase-producing Hi strains (such as daycare center attendance, otitis-prone condition or recent antibiotic use). CONCLUSION: In France, the nasopharyngeal carriage rate of reduced-susceptibility pneumococcal strains and ß-lactamase-producing Hi strains decreased in children with acute otitis media after 2010, the year the PCV13 was introduced. Accordingly, amoxicillin as the first-line drug for acute otitis media requiring antibiotics remains a valid choice.


Subject(s)
Haemophilus influenzae/drug effects , Pneumococcal Vaccines/administration & dosage , Streptococcus pneumoniae/drug effects , Acute Disease , Anti-Bacterial Agents/therapeutic use , Child, Preschool , Drug Resistance, Microbial , Female , France , Haemophilus influenzae/isolation & purification , Humans , Infant , Male , Nasopharynx/microbiology , Otitis Media/microbiology , Streptococcus pneumoniae/immunology , Streptococcus pneumoniae/isolation & purification , beta-Lactamases/drug effects
10.
J Clin Microbiol ; 52(11): 3890-7, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25143574

ABSTRACT

Although Kingella kingae is the most common etiology of osteoarticular infections in young children, is a frequent cause of bacteremia in those younger than 4 years, and has been involved in clusters of invasive infections among daycare center attendees, the population structure of the species has not been systematically studied. Using multilocus sequence typing, we investigated the genetic diversity of the largest intercontinental collection of K. kingae strains to date. To facilitate typing of bacterial isolates, we developed a novel genotyping tool that targets the DNA uptake sequence (DUS). Among 324 strains isolated from asymptomatic carriers and patients from Israel, Europe, North America, and Australia with various invasive forms of the disease from 1960 to 2013, we identified 64 sequence types (STs) and 12 ST complexes (STcs). Five predominant STcs, comprising 72.2% of all strains, were distributed intercontinentally. ST-6 was the most frequent, showing a worldwide distribution, and appeared genotypically isolated by exhibiting few neighboring STs, suggesting an optimal fitness. ST-14 and ST-23 appeared to be the oldest groups of bacteria, while ST-25 probably emerged more recently from the highly evolutive ST-23. Using the DUS typing method, randomly chosen isolates were correctly classified to one of the major STcs. The comprehensive description of K. kingae evolution would help to detect new emerging clones and decipher virulence and fitness mechanisms. The rapid and reproducible DUS typing method may serve in the initial investigation of K. kingae outbreaks.


Subject(s)
Genetic Variation , Kingella kingae/classification , Kingella kingae/isolation & purification , Multilocus Sequence Typing/methods , Neisseriaceae Infections/epidemiology , Neisseriaceae Infections/microbiology , Australia/epidemiology , Child, Preschool , Cluster Analysis , Europe/epidemiology , Genotype , Humans , Infant , Israel/epidemiology , Kingella kingae/genetics , Molecular Epidemiology/methods , North America/epidemiology , Osteoarthritis/epidemiology , Osteoarthritis/microbiology , Reproducibility of Results , Time Factors
11.
Int J Clin Pharmacol Ther ; 52(11): 940-7, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25161154

ABSTRACT

OBJECTIVE: Numerous studies have shown that the tolerance of children to fluoroquinolones (FQs) is satisfactory, and some indications have been recently agreed upon. However, vigilance is required when prescribing FQ to children. The aim of our study was to describe the prescription of FQs to children hospitalized in our hospital. MATERIALS AND METHODS: This is a chart retrospective observational study at the Robert-Debré teaching Hospital between January 2009 and December 2010. Data was collected about patients (name, sex, weight, age) and prescribed treatments (indication, international nonproprietary names, dose, number of doses per day, administration route). Quality of collected data was assessed by analyzing the clinical files of 32 randomly selected patients. RESULTS: We analyzed data for 397 patients (3 days - 18 years old and 640 g - 115 kg). Ciprofloxacin was prescribed for 382 patients (96%), ofloxacin for 10 patients (3%), and levofloxacin for 5 patients (1%). Febrile neutropenia was the most common indication (108 patients, i.e., 27%), followed by inflammatory bowel disease (50 patients, 13%). Doses conformed to recommendations for 88% of the patients. Analysis of the 32 cases indicated an overall compliance percentage of 94.4%. CONCLUSION: This is the first study to collect so much data on FQ prescriptions for hospitalized children. Use in practice went beyond the licensed indication. Doses were consistent with those for recommended indications.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Utilization Review , Fluoroquinolones/therapeutic use , Adolescent , Child , Child, Preschool , Drug Resistance, Bacterial , Febrile Neutropenia/drug therapy , Female , Fluoroquinolones/adverse effects , Humans , Infant , Infant, Newborn , Inflammatory Bowel Diseases/drug therapy , Male , Retrospective Studies
13.
J Clin Microbiol ; 51(6): 1727-32, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23515552

ABSTRACT

Maternal-fetal Escherichia coli infections, such as neonatal bacteremia and meningitis, are important causes of morbidity and mortality. From 2006 to 2010, we studied newborns and their mothers who were colonized with E. coli in a French hospital in order to document (i) the epidemiology and genetic characteristics of extended-spectrum-beta-lactamase (ESBL)-producing E. coli strains, (ii) the prevalence of associated virulence genes, (iii) the prevalence of clone sequence type 131 (ST131), and (iv) the genetic relationship among ESBL-producing strains. Among the 2,755 E. coli cultures recovered from vaginal or neonatal samples, 68 were ESBL producers (2.46%). We found a wide diversity of ESBL genes, with the majority being bla(CTX-M-14), bla(CTX-M-1), and bla(CTX-M-15), distributed among the 4 main phylogenetic groups. Genes encoding virulence factors were found in 90.7% of the isolates, with ≥ 2 virulence genes present in 76% of cases. The prevalence of ST131 among ESBL-producing E. coli isolates was 9.4% (6/64). Five of these 6 ST131 isolates possessed bla(CTX-M-15) enzymes (and also were resistant to quinolones), and one possessed bla(CTX-M-2) enzymes. Two possessed virulence genes, suggesting the presence of pathogenicity island IIJ96 (PAI IIJ96)-like domains. Pulsed-field gel electrophoresis (PFGE) revealed a high level of genomic diversity overall, except for 3 closely related isolates belonging to clonal group ST131. Repetitive PCR showed that the six ST131 isolates were closely related to ST131 control strains (>95% similarity). This study shows a high prevalence of ESBL-producing E. coli strains and clonal group ST131 in the French maternal-fetal population. These results suggest a widespread distribution of ESBL enzymes in the community and highlight the early transmission between mothers and neonates. These findings are worrisome, especially for this particularly vulnerable population.


Subject(s)
Disease Transmission, Infectious , Escherichia coli Infections/microbiology , Escherichia coli Infections/transmission , Escherichia coli/classification , Escherichia coli/enzymology , beta-Lactamases/metabolism , Adult , Blood/microbiology , Cerebrospinal Fluid/microbiology , Cluster Analysis , Escherichia coli/genetics , Escherichia coli/isolation & purification , Escherichia coli Infections/epidemiology , Female , France , Genetic Variation , Genotype , Humans , Infant, Newborn , Molecular Epidemiology , Molecular Typing , Phylogeny , Prevalence , Vagina/microbiology , Virulence Factors/genetics
14.
J Clin Microbiol ; 51(9): 3137-9, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23784119

ABSTRACT

We describe two atypical cases of Kingella kingae infection in children diagnosed by PCR, one case involving a soft tissue abscess and one case a femoral Brodie abscess. Both patients had concomitant human rhinovirus infection. K. kingae strains, isolated from an oropharyngeal swab, were characterized by multilocus sequence typing and rtxA sequencing.


Subject(s)
Abscess/complications , Abscess/microbiology , Kingella kingae/isolation & purification , Neisseriaceae Infections/complications , Neisseriaceae Infections/microbiology , Picornaviridae Infections/diagnosis , Rhinovirus/isolation & purification , Bacterial Proteins/genetics , Female , Humans , Infant , Kingella kingae/classification , Kingella kingae/genetics , Multilocus Sequence Typing , Oropharynx/microbiology , Picornaviridae Infections/virology
15.
Arch Pediatr ; 30(3): 153-157, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36822930

ABSTRACT

BACKGROUND: Staphylococcus aureus (SA) is one of the main pathogens responsible for healthcare-associated infection (HCAI) in pediatrics. The aim of this study was to describe the prevalence of SA-HCAI among colonized patients and the factors associated with it in the pediatric intensive care unit (PICU). METHODS: We designed a 6-year retrospective cohort study of a PICU in a French university children's hospital including all children admitted to the PICU from January 1, 2011, to December 31, 2016, who had SA colonization on PICU admission. For each patient, the past medical history and the hospitalization data were collected. HCAIs related to SA were verified according to the criteria of the United States Centers for Disease Control and Prevention. RESULTS: Among all patients colonized with SA (n = 1381, 26%), 105 (8%) had methicillin-resistant SA carriage and 41 (3%) developed an HCAI caused by SA. The main HCAIs were ventilator-associated pneumonia (51%) and central line-associated bloodstream infections (27%). Patients developing HCAI caused by SA had a significantly longer length of hospital stay and a higher mortality rate than the rest of the population. Using a multivariate logistic regression model, the presence of mechanical ventilation, the implementation of a surgical procedure during the PICU stay, and the onset of at least one episode of anemia during the PICU stay were significantly associated with the occurrence of HCAI due to SA. CONCLUSION: HCAIs linked to SA carriage are rare but severe. Mechanical ventilation, surgery during the PICU stay, and anemia are factors associated with SA-HCAI.


Subject(s)
Cross Infection , Staphylococcal Infections , Humans , Child , Infant , Staphylococcus aureus , Retrospective Studies , Staphylococcal Infections/epidemiology , Cross Infection/epidemiology , Intensive Care Units, Pediatric , Delivery of Health Care
16.
J Clin Microbiol ; 50(4): 1295-302, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22259214

ABSTRACT

Dissemination of carbapenem resistance among Enterobacteriaceae poses a considerable threat to public health. Carbapenemase gene detection by molecular methods is the gold standard but is available in only a few laboratories. The aim of this study was to test phenotypic methods for the detection of metallo-ß-lactamase (MBL)- or Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae and associated mechanisms of ß-lactam resistance against a panel of 30 genotypically characterized carbapenem-resistant Enterobacteriaceae : 9 MBL, 7 KPC, 6 OXA-48, and 8 extended-spectrum ß-lactamase (ESBL) or AmpC ß-lactamases associated with decreased permeability. We used carbapenemase inhibitor-impregnated agar to test for carbapenem-resistant strains. Differences in the inhibition zone sizes of the meropenem, imipenem, ertapenem, and doripenem disks were measured between control and inhibitor (EDTA or phenylboronic acid [PBA] with or without cloxacillin)-impregnated Mueller-Hinton agar with a cutoff of 10 mm. All 9 MBL- and 7 KPC-producing Enterobacteriaceae were identified from the differences in zone size in the presence and absence of specific inhibitors, regardless of the carbapenem MICs and including isolates with low-level resistance to carbapenems. We also detected their associated ß-lactam resistance mechanisms (11 ESBL-type and 5 class A ß-lactamase 2b). No differences in zone size were observed for OXA-48-producing strains or other carbapenem resistance mechanisms such as ESBL and decreased permeability. We propose a new strategy to detect carbapenemases (MBL- and KPC-type) and associated mechanisms of ß-lactam resistance (ESBL or class A ß-lactamase 2b) by the use of inhibitor-impregnated agar. A rapid phenotypic detection of resistance mechanisms is important for epidemiological purposes and for limiting the spread of resistant strains by implementing specific infection control measures.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Carbapenems/pharmacology , Enterobacteriaceae/enzymology , beta-Lactam Resistance/genetics , beta-Lactamases/genetics , Disk Diffusion Antimicrobial Tests , Enterobacteriaceae/drug effects , Enterobacteriaceae/genetics , Phenotype
17.
Eur J Pediatr ; 171(9): 1365-71, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22527566

ABSTRACT

We performed a cohort study of children who survived bacterial meningitis after the neonatal period at a single pediatric center in France over a 10-year period (1995-2004) to identify predictors of death and long-term neurological deficits in children with bacterial meningitis. We performed multivariate regression to determine independent predictors of death and neurologic deficits. We identified 101 children with bacterial meningitis of which 19 died during initial hospitalization. Need for mechanical ventilation [hazard ratio (HR) 11.5, 95 % confidence interval (CI) 2.4-55.5)] and thrombocytopenia defined as a platelet count <150 × 10(9) per liter (HR 0.6, 95 % CI 0.4-0.9) at presentation were associated with death during initial hospitalization. At final assessment, 42 of the 70 survivors had no neurologic deficits identified; 20 had a single deficit, and eight had multiple deficits. A delay in initiation of antibiotics (HR 1.3, 95 % CI 1.1-1.7) and hydrocephalus on computed tomographic scan (HR 2.6, 95 % CI 1.1-6.0) were associated with having one or more long-term neurologic deficits. Identification of children at risk of death or long-term neurologic sequelae may allow therapeutic interventions to be directed to children at the highest risk.


Subject(s)
Meningitis, Bacterial/complications , Mental Disorders/etiology , Nervous System Diseases/etiology , Cohort Studies , Epilepsy/etiology , Female , Follow-Up Studies , Hearing Loss, Sensorineural/etiology , Hospital Mortality , Hospitalization , Humans , Infant , Intellectual Disability/etiology , Male , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/mortality , Meningitis, Bacterial/therapy , Migraine Disorders/etiology , Movement Disorders/etiology , Multivariate Analysis , Prognosis , Proportional Hazards Models , Retrospective Studies , Risk Factors , Sleep Wake Disorders/etiology , Treatment Outcome
18.
J Clin Microbiol ; 49(8): 3085-7, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21653781

ABSTRACT

Rapid identification of metallo-ß-lactamase-producing Gram-negative species is crucial for the timely implementation of infection control measures. We describe two pediatric cases in which colonization by VIM-1- and New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae was rapidly detected by phenotypic and genotypic methods. Phenotypic methods can be useful for routine detection of carbapenemase production.


Subject(s)
Escherichia coli Infections/diagnosis , Escherichia coli/enzymology , Klebsiella Infections/diagnosis , Klebsiella pneumoniae/enzymology , beta-Lactamases/biosynthesis , Bacteriological Techniques/methods , Escherichia coli/isolation & purification , Escherichia coli Infections/microbiology , France , Genotype , Humans , Infant , Klebsiella Infections/microbiology , Klebsiella pneumoniae/isolation & purification , Male , Phenotype
19.
Sci Rep ; 10(1): 589, 2020 01 17.
Article in English | MEDLINE | ID: mdl-31953453

ABSTRACT

Through their action on DNA replication, anticancer chemotherapies could increase the basal mutation rate in bacteria and increase the risk of selecting antibiotic resistant mutants. We investigated the impact of several drugs on a beta-lactamase model using KPC-type carbapenemase-producing Enterobacteriaceae. We studied the impact of anticancer chemotherapies used in pediatric hematologic malignancies on 7 clinical isolates of Enterobacteriaceae producing KPC-type carbapenemases. We compared the mutation rates from cultures with/without chemotherapy on ceftazidime-avibactam, rifampicin and ceftazidime-avibactam combined with meropenem media. Mechanisms of ceftazidime-avibactam resistance were explored on a subset of mutants. After exposure to some cytotoxic molecules, the bacterial mutation rates leading to ceftazidime-avibactam and to rifampicin resistance increased up to 104-fold while we observed no emergence of resistant mutants (frequency of <10-10) on a meropenem combined with ceftazidime-avibactam media. Compared to the parental strains, an increased susceptibility to meropenem was observed in the ceftazidime-avibactam resistant mutants. The blaKPC genes of ceftazidime-avibactam mutants harbored either mutations, deletions or insertions, especially in the region encoding the Ω-loop of the KPC-type carbapenemase. Anticancer chemotherapy can increase the mutation rates of bacteria accelerating the extension of KPC-type carbapenemases towards ceftazidime-avibactam, one of the last resort antimicrobial chemotherapy.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antineoplastic Agents/adverse effects , Carbapenem-Resistant Enterobacteriaceae/drug effects , Mutation , beta-Lactamases/genetics , Azabicyclo Compounds/pharmacology , Bacterial Proteins/genetics , Carbapenem-Resistant Enterobacteriaceae/genetics , Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Ceftazidime/pharmacology , Drug Combinations , Drug Resistance, Bacterial , Enterobacteriaceae Infections/microbiology , Genome, Bacterial , Humans , Meropenem/pharmacology , Microbial Sensitivity Tests , Rifampin/pharmacology , Whole Genome Sequencing
20.
J Clin Microbiol ; 47(3): 837-40, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19109482

ABSTRACT

Serotype 19A Streptococcus pneumoniae strains are now more frequent in French children than before the introduction of a seven-valent conjugate vaccine (PCV7). By applying multilocus sequence typing to 144 serotype 19A isolates collected before and after beginning PCV7 vaccination, we detected clonal expansion of the preexisting penicillin-intermediate sequence type 276.


Subject(s)
Pneumococcal Infections/epidemiology , Pneumococcal Infections/microbiology , Pneumococcal Vaccines/immunology , Streptococcus pneumoniae/isolation & purification , Anti-Bacterial Agents/pharmacology , Bacterial Typing Techniques , Cluster Analysis , France/epidemiology , Genotype , Heptavalent Pneumococcal Conjugate Vaccine , Humans , Infant , Penicillins/pharmacology , Prevalence , Sequence Analysis, DNA , Serotyping
SELECTION OF CITATIONS
SEARCH DETAIL